ACUTE MYELOID LEUKEMIA WITH INV(3) (Q21.3;Q26.2); GATA2, MECOM

Clinical trials for ACUTE MYELOID LEUKEMIA WITH INV(3) (Q21.3;Q26.2); GATA2, MECOM explained in plain language.

Never miss a new study

Get alerted when new ACUTE MYELOID LEUKEMIA WITH INV(3) (Q21.3;Q26.2); GATA2, MECOM trials appear

Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIA WITH INV(3) (Q21.3;Q26.2); GATA2, MECOM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Gentler transplant strategy tested for tough blood cancers

Disease control Completed

This study tested a two-step, lower-intensity stem cell transplant for patients with high-risk blood cancers like leukemia and lymphoma. The goal was to control the cancer by first using low-dose chemotherapy and radiation to prepare the body, then infusing donor stem cells to at…

Matched conditions: ACUTE MYELOID LEUKEMIA WITH INV(3) (Q21.3;Q26.2); GATA2, MECOM

Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control

Last updated Apr 02, 2026 02:42 UTC

ACUTE MYELOID LEUKEMIA WITH INV(3) (Q21.3;Q26.2); GATA2, MECOM

Get alerted when new ACUTE MYELOID LEUKEMIA WITH INV(3) (Q21.3;Q26.2); GATA2, MECOM trials appear

Gentler transplant strategy tested for tough blood cancers